Compare Grab Holdings Ltd. (GRAB) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grab Holdings Ltd. vs Oruka Therapeutics Inc. Common Stock — how do they compare? Grab Holdings Ltd. trades at $2.88 (market cap $11.91B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Grab Holdings Ltd. is far larger — about 2.3× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| GRAB | ORKA | |
|---|---|---|
Market Cap | $11.91B | $5.08B |
Volume | 62,622,940 | 685,276 |
Sector | Technology | Health |
52-Week High | $6.12 | $113.08 |
52-Week Low | $2.80 | $26.19 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $7.64B | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GRAB Holdings Limited (GRAB) trades at $2.98, down 5.4% on the day, amid a bearish technical signal. Fundamentally, the company shows strong improvement with revenue growing to $3.37B in 2025 and net income turning positive at $268M. Recent Q2 2026 earnings beat expectations with EPS of $0.06 versus $0.05 expected. The company is expanding aggressively with a $1.49B acquisition of a majority stake in Atome Financial, targeting financial services growth.
The outlook is mixed: strong analyst support (91.67% buy ratings) and insider buying signal confidence, but technical weakness and high capital expenditure for acquisitions pose near-term risks. Profitability trends are positive, yet competitive pressures in Southeast Asia and integration challenges from recent M&A are key watchpoints for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
